Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
There are no as such competitors for Dermata Therapeutics.
Dermata Therapeutics has a consensus price target of $10.00.
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $1.33 last updated July 14, 2026 at 7:34 PM EDT.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.